Volume Expansion with Starch HES 130/0.4 vs. Acetated Ringer’s Solution on Haemodynamics in CABG Surgery Monitored by FloTrac/Vigileo TM System

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-11001608

Enrollment

Unknown

Registered

2011-01-27

Start date

2011-03-07

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary heart disease

Interventions

Group A:Acetated ringer's solution 10ml/kg iv

Group C:Acetated ringer's solution 2ml/kg/h iv drip

S group:starch HES 130/0.4 10ml/kg iv

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Selective coronary arterial bypass graft surgery.

Exclusion criteria

Exclusion criteria: 1. Reduced left ventricular function (ejection fraction 2.5 times normal) or renal (serum creatinine > 1.3 mg/dL) dysfunction. 6. Patients judged under standard anaesthesia criteria to have a difficult airway.

Design outcomes

Primary

Measure	Time frame
hemodynamic;	—

Secondary

Measure	Time frame
hepatic and renal function;	—

Countries

China

Contacts

Public ContactZhiguo Yuan

zhiguoyuan_73zhiguoyuan@hotmail.com+86 13840466665

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026